[1] Kopin L, Lowenstein C.Dyslipidemia[J].Ann Intern Med,2017,167(11):81-96. [2] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953. [3] 国家卫生和计划生育委员会疾病预防控制局.中国居民营养与慢性病状况报告(2015年)[M].北京:人民卫生出版社,2015:1. [4] 莫景富,宋秀玲,许燕君,等.广东省成人血脂异常患病率及其危险因素的相关性研究[J].华南预防医学,2013,39(2):11-17. [5] Weingartner O, Lutjohann D, Plosch T, et al.Individualized lipid-lowering therapy to further reduce residual cardiovascular risk[J].J Steroid Biochem Mol Biol,2017,169:198-201. [6] Sanin V, Pfetsch V, Koenig W.Dyslipidemias and cardiovascular prevention: Tailoring treatment according to lipid phenotype[J].Curr Cardiol Rep,2017,19(7):61. [7] 张云鹤,何青.中国血脂异常流行病学特点[J].中华保健医学杂志,2015,17(3):254-256. [8] 赵永娜,于凯,冀瑞俊,等.河北任丘老年居民血脂异常及其危险因素筛查分析[J].中华老年心脑血管病杂志,2015,17(6):570-574. [9] 尚庆刚,吴志兴,雷林,等.深圳市2015年居民血脂异常流行病学调查[J].中国热带医学,2018, 18(5):464-468. [10] Zhang CX, Ho SC.Validity and reproducibility of a food frequency questionnaire among Chinese women in Guangdong province[J].Asia Pac J Clin Nutr,2009,18(2):240-250. [11] Lu MS, Fang YJ, Pan ZZ, et al.Choline and betaine intake and colorectal cancer risk in Chinese population: A case-control study[J].PLoS One,2015,10(3):e0118661. [12] 中华医学会健康管理学分会,中国营养学会,中国医疗保健国际交流促进会生殖医学分会,等.超重或肥胖人群体重管理专家共识及团体标准[J].中华健康管理学杂志,2018,12(3):200-207. [13] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. [14] 何清懿. 社区老年人血脂异常流行特征及影响因素分析[J].中国卫生产业,2018,15(20):192-194. [15] 戴璟,闵杰青,杨云娟.中国九省市成年人血脂异常流行特点研究[J].中华心血管病杂志,2018,46(2):114-118. [16] 王心怡. 合肥市45~60岁健康体检人群血脂异常的患病率及其影响因素分析[D].合肥:安徽医科大学,2017. [17] 杨丽群,李荣,段晓云,等.大理市社区中老年居民血脂血糖异常现状分析[J].医学理论与实践,2018,31(5):757-759. [18] 冯祥,华召来,周琴,等.某市中老年居民主要慢性病患病现况及共病模式分析[J].现代预防医学,2019,46(20):3728-3731,3753. [19] Morgan AE, Mooney KM, Wilkinson SJ, et al.Cholesterol metabolism:A review of how ageing disrupts the biological mechanisms responsible for its regulation[J].Ageing Res Rev,2016,27:108-124. [20] Liu HH, Li JJ.Aging and dyslipidemia: a review of potential mechanisms[J].Ageing Res Rev,2015,19:43-52. [21] Cifkova R, Krajcoviechova A.Dyslipidemia and cardiovascular disease in women[J].Curr Cardiol Rep,2015,17(7):609. [22] 惠朝晖,方瑶,徐珊,等.深圳市南山区某高科技企业员工超重或肥胖、尿酸与血脂关联性[J].华南预防医学,2019,45(3):272-274,296. [23] 刘玉萍. 大学教职工血脂异常合并高血压发生情况及影响因素分析[J].华南预防医学,2017,43(3):287-290. [24] Zhang TH, Chen J, Tang XY, et al.Interaction between adipocytes and high-density lipoprotein:New insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis[J]. Lipids Health Dis,2019,18(1):223. [25] Vekic J, Zeljkovic A, Stefanovic A, et al.Obesity and dyslipidemia[J]. Metabolism,2019,92:71-81. [26] Ipsen DH, Tveden-Nyborg P, Lykkesfeldt J.Dyslipidemia: Obese or not obese-that is not the question[J].Curr Obes Rep,2016,5(4):405-412. |